WO2022220521A1 - 양친매성 화합물, 이의 제조방법 및 이를 포함하는 계면활성제 조성물 - Google Patents
양친매성 화합물, 이의 제조방법 및 이를 포함하는 계면활성제 조성물 Download PDFInfo
- Publication number
- WO2022220521A1 WO2022220521A1 PCT/KR2022/005227 KR2022005227W WO2022220521A1 WO 2022220521 A1 WO2022220521 A1 WO 2022220521A1 KR 2022005227 W KR2022005227 W KR 2022005227W WO 2022220521 A1 WO2022220521 A1 WO 2022220521A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- glucose
- steviol
- acid
- monoglycoside
- formula
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 41
- 150000001875 compounds Chemical class 0.000 title claims abstract description 27
- 239000004094 surface-active agent Substances 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 title abstract 3
- QFVOYBUQQBFCRH-UHFFFAOYSA-N Steviol Natural products C1CC2(C3)CC(=C)C3(O)CCC2C2(C)C1C(C)(C(O)=O)CCC2 QFVOYBUQQBFCRH-UHFFFAOYSA-N 0.000 claims abstract description 102
- 229940032084 steviol Drugs 0.000 claims abstract description 102
- QFVOYBUQQBFCRH-VQSWZGCSSA-N steviol Chemical compound C([C@@]1(O)C(=C)C[C@@]2(C1)CC1)C[C@H]2[C@@]2(C)[C@H]1[C@](C)(C(O)=O)CCC2 QFVOYBUQQBFCRH-VQSWZGCSSA-N 0.000 claims abstract description 101
- 239000002253 acid Substances 0.000 claims abstract description 63
- NHUFMXNVSAWNTO-NMYAFYTPSA-N OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O.OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O.OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O NHUFMXNVSAWNTO-NMYAFYTPSA-N 0.000 claims description 152
- 125000000217 alkyl group Chemical group 0.000 claims description 37
- 125000003118 aryl group Chemical group 0.000 claims description 27
- 125000004122 cyclic group Chemical group 0.000 claims description 25
- UMTFHBLNQSVISL-OAELFMBBSA-N O[C@H]1[C@H](O)[C@@H](O)[C@H](O)CO1.O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)CO1.O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO UMTFHBLNQSVISL-OAELFMBBSA-N 0.000 claims description 22
- 150000001412 amines Chemical class 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 18
- 230000009435 amidation Effects 0.000 claims description 17
- 238000007112 amidation reaction Methods 0.000 claims description 17
- 239000000126 substance Substances 0.000 claims description 16
- 125000003545 alkoxy group Chemical group 0.000 claims description 11
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 11
- 238000005809 transesterification reaction Methods 0.000 claims description 9
- 239000004480 active ingredient Substances 0.000 claims description 2
- 230000003301 hydrolyzing effect Effects 0.000 claims description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 54
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 54
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 46
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 36
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 30
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 27
- 239000000047 product Substances 0.000 description 25
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 24
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 23
- 238000006555 catalytic reaction Methods 0.000 description 22
- 239000003960 organic solvent Substances 0.000 description 22
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 21
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 20
- 239000003054 catalyst Substances 0.000 description 18
- 239000000243 solution Substances 0.000 description 18
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 16
- 150000001298 alcohols Chemical class 0.000 description 16
- 239000003513 alkali Substances 0.000 description 16
- 230000007062 hydrolysis Effects 0.000 description 16
- 238000006460 hydrolysis reaction Methods 0.000 description 16
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- 238000006243 chemical reaction Methods 0.000 description 14
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 13
- 239000013543 active substance Substances 0.000 description 13
- 230000032050 esterification Effects 0.000 description 13
- 238000005886 esterification reaction Methods 0.000 description 13
- -1 steviol diterpenoids Chemical class 0.000 description 13
- FVKFHMNJTHKMRX-UHFFFAOYSA-N 3,4,6,7,8,9-hexahydro-2H-pyrimido[1,2-a]pyrimidine Chemical compound C1CCN2CCCNC2=N1 FVKFHMNJTHKMRX-UHFFFAOYSA-N 0.000 description 12
- GSNUFIFRDBKVIE-UHFFFAOYSA-N DMF Natural products CC1=CC=C(C)O1 GSNUFIFRDBKVIE-UHFFFAOYSA-N 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 12
- 239000001512 FEMA 4601 Substances 0.000 description 11
- HELXLJCILKEWJH-SEAGSNCFSA-N Rebaudioside A Natural products O=C(O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@]1(C)[C@@H]2[C@](C)([C@H]3[C@@]4(CC(=C)[C@@](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](CO)O5)(C4)CC3)CC2)CCC1 HELXLJCILKEWJH-SEAGSNCFSA-N 0.000 description 11
- HELXLJCILKEWJH-UHFFFAOYSA-N entered according to Sigma 01432 Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O HELXLJCILKEWJH-UHFFFAOYSA-N 0.000 description 11
- 235000019203 rebaudioside A Nutrition 0.000 description 11
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 10
- 239000004215 Carbon black (E152) Substances 0.000 description 10
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 10
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 10
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 10
- 125000000753 cycloalkyl group Chemical group 0.000 description 10
- 150000002148 esters Chemical class 0.000 description 10
- 229930195733 hydrocarbon Natural products 0.000 description 10
- 150000002430 hydrocarbons Chemical class 0.000 description 10
- 150000002576 ketones Chemical class 0.000 description 10
- 229910017604 nitric acid Inorganic materials 0.000 description 10
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 8
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 8
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 8
- VSTXCZGEEVFJES-UHFFFAOYSA-N 1-cycloundecyl-1,5-diazacycloundec-5-ene Chemical compound C1CCCCCC(CCCC1)N1CCCCCC=NCCC1 VSTXCZGEEVFJES-UHFFFAOYSA-N 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 7
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 7
- 125000005907 alkyl ester group Chemical group 0.000 description 7
- 239000002585 base Substances 0.000 description 7
- 150000002357 guanidines Chemical class 0.000 description 7
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 7
- 229940013618 stevioside Drugs 0.000 description 7
- 235000019202 steviosides Nutrition 0.000 description 7
- 108010031797 Candida antarctica lipase B Proteins 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 6
- 150000001408 amides Chemical class 0.000 description 6
- 230000002255 enzymatic effect Effects 0.000 description 6
- 239000006260 foam Substances 0.000 description 6
- 239000000693 micelle Substances 0.000 description 6
- 239000003791 organic solvent mixture Substances 0.000 description 6
- 239000012265 solid product Substances 0.000 description 6
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 5
- 239000002841 Lewis acid Substances 0.000 description 5
- 239000002879 Lewis base Substances 0.000 description 5
- OMHUCGDTACNQEX-OSHKXICASA-N Steviolbioside Natural products O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(O)=O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O OMHUCGDTACNQEX-OSHKXICASA-N 0.000 description 5
- MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical class O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 5
- 150000001450 anions Chemical class 0.000 description 5
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 5
- 150000001768 cations Chemical class 0.000 description 5
- JLPRGBMUVNVSKP-AHUXISJXSA-M chembl2368336 Chemical compound [Na+].O([C@H]1[C@@H](O)[C@H](O)[C@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C([O-])=O)[C@@H]1O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]1O JLPRGBMUVNVSKP-AHUXISJXSA-M 0.000 description 5
- 239000011964 heteropoly acid Substances 0.000 description 5
- 150000007517 lewis acids Chemical class 0.000 description 5
- 150000007527 lewis bases Chemical class 0.000 description 5
- 229910044991 metal oxide Inorganic materials 0.000 description 5
- 150000004706 metal oxides Chemical class 0.000 description 5
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 5
- 239000011970 polystyrene sulfonate Substances 0.000 description 5
- 229960002796 polystyrene sulfonate Drugs 0.000 description 5
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 238000007056 transamidation reaction Methods 0.000 description 5
- 229910000314 transition metal oxide Inorganic materials 0.000 description 5
- 239000010457 zeolite Substances 0.000 description 5
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 4
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 4
- 108090001060 Lipase Proteins 0.000 description 4
- 239000004367 Lipase Substances 0.000 description 4
- 102000004882 Lipase Human genes 0.000 description 4
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 229910007926 ZrCl Inorganic materials 0.000 description 4
- 239000003377 acid catalyst Substances 0.000 description 4
- 150000004982 aromatic amines Chemical class 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- 230000008020 evaporation Effects 0.000 description 4
- 125000003147 glycosyl group Chemical group 0.000 description 4
- 235000019421 lipase Nutrition 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 4
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 4
- 230000035484 reaction time Effects 0.000 description 4
- QSRAJVGDWKFOGU-WBXIDTKBSA-N rebaudioside c Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]1(CC[C@H]2[C@@]3(C)[C@@H]([C@](CCC3)(C)C(=O)O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)CC3)C(=C)C[C@]23C1 QSRAJVGDWKFOGU-WBXIDTKBSA-N 0.000 description 4
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 4
- 238000005481 NMR spectroscopy Methods 0.000 description 3
- IGFHQQFPSIBGKE-UHFFFAOYSA-N Nonylphenol Natural products CCCCCCCCCC1=CC=C(O)C=C1 IGFHQQFPSIBGKE-UHFFFAOYSA-N 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000003599 detergent Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 230000009931 harmful effect Effects 0.000 description 3
- SNQQPOLDUKLAAF-UHFFFAOYSA-N nonylphenol Chemical group CCCCCCCCCC1=CC=CC=C1O SNQQPOLDUKLAAF-UHFFFAOYSA-N 0.000 description 3
- 239000012044 organic layer Substances 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- BMVXCPBXGZKUPN-UHFFFAOYSA-N 1-hexanamine Chemical compound CCCCCCN BMVXCPBXGZKUPN-UHFFFAOYSA-N 0.000 description 2
- 108090000531 Amidohydrolases Proteins 0.000 description 2
- 102000004092 Amidohydrolases Human genes 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- CANAPGLEBDTCAF-NTIPNFSCSA-N Dulcoside A Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@]23C(C[C@]4(C2)[C@H]([C@@]2(C)[C@@H]([C@](CCC2)(C)C(=O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)CC4)CC3)=C)O[C@H](CO)[C@@H](O)[C@@H]1O CANAPGLEBDTCAF-NTIPNFSCSA-N 0.000 description 2
- CANAPGLEBDTCAF-QHSHOEHESA-N Dulcoside A Natural products C[C@@H]1O[C@H](O[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2O[C@]34CC[C@H]5[C@]6(C)CCC[C@](C)([C@H]6CC[C@@]5(CC3=C)C4)C(=O)O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H](O)[C@H](O)[C@H]1O CANAPGLEBDTCAF-QHSHOEHESA-N 0.000 description 2
- 108090000371 Esterases Proteins 0.000 description 2
- 239000001776 FEMA 4720 Substances 0.000 description 2
- 239000007821 HATU Substances 0.000 description 2
- 241001661345 Moesziomyces antarcticus Species 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- 241000544066 Stevia Species 0.000 description 2
- 238000007171 acid catalysis Methods 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 2
- 239000012267 brine Substances 0.000 description 2
- 150000001718 carbodiimides Chemical class 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- DIBHLCJAJIKHGB-UHFFFAOYSA-N dec-5-ene Chemical compound [CH2]CCCC=CCCCC DIBHLCJAJIKHGB-UHFFFAOYSA-N 0.000 description 2
- 229960005309 estradiol Drugs 0.000 description 2
- 229940093499 ethyl acetate Drugs 0.000 description 2
- 235000019439 ethyl acetate Nutrition 0.000 description 2
- 239000000383 hazardous chemical Substances 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- NIQQIJXGUZVEBB-UHFFFAOYSA-N methanol;propan-2-one Chemical compound OC.CC(C)=O NIQQIJXGUZVEBB-UHFFFAOYSA-N 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- IOQPZZOEVPZRBK-UHFFFAOYSA-N octan-1-amine Chemical compound CCCCCCCCN IOQPZZOEVPZRBK-UHFFFAOYSA-N 0.000 description 2
- 239000003973 paint Substances 0.000 description 2
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- NSETWVJZUWGCKE-UHFFFAOYSA-N propylphosphonic acid Chemical compound CCCP(O)(O)=O NSETWVJZUWGCKE-UHFFFAOYSA-N 0.000 description 2
- 229930188195 rebaudioside Natural products 0.000 description 2
- RPYRMTHVSUWHSV-CUZJHZIBSA-N rebaudioside D Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RPYRMTHVSUWHSV-CUZJHZIBSA-N 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- IEORSVTYLWZQJQ-UHFFFAOYSA-N 2-(2-nonylphenoxy)ethanol Chemical compound CCCCCCCCCC1=CC=CC=C1OCCO IEORSVTYLWZQJQ-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- RLLCWNUIHGPAJY-RYBZXKSASA-N Rebaudioside E Natural products O=C(O[C@H]1[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O2)[C@@H](O)[C@@H](O)[C@H](CO)O1)[C@]1(C)[C@@H]2[C@@](C)([C@@H]3[C@@]4(CC(=C)[C@@](O[C@@H]5[C@@H](O[C@@H]6[C@@H](O)[C@H](O)[C@@H](O)[C@H](CO)O6)[C@H](O)[C@@H](O)[C@H](CO)O5)(C4)CC3)CC2)CCC1 RLLCWNUIHGPAJY-RYBZXKSASA-N 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 235000006092 Stevia rebaudiana Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 150000004141 diterpene derivatives Chemical group 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 102000015694 estrogen receptors Human genes 0.000 description 1
- 108010038795 estrogen receptors Proteins 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 239000000976 ink Substances 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000005555 metalworking Methods 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 229920000847 nonoxynol Polymers 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000003090 pesticide formulation Substances 0.000 description 1
- 239000003348 petrochemical agent Substances 0.000 description 1
- 125000005498 phthalate group Chemical class 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- RLLCWNUIHGPAJY-SFUUMPFESA-N rebaudioside E Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RLLCWNUIHGPAJY-SFUUMPFESA-N 0.000 description 1
- QRGRAFPOLJOGRV-UHFFFAOYSA-N rebaudioside F Natural products CC12CCCC(C)(C1CCC34CC(=C)C(CCC23)(C4)OC5OC(CO)C(O)C(OC6OCC(O)C(O)C6O)C5OC7OC(CO)C(O)C(O)C7O)C(=O)OC8OC(CO)C(O)C(O)C8O QRGRAFPOLJOGRV-UHFFFAOYSA-N 0.000 description 1
- HYLAUKAHEAUVFE-AVBZULRRSA-N rebaudioside f Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)CO1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HYLAUKAHEAUVFE-AVBZULRRSA-N 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- DRSKVOAJKLUMCL-MMUIXFKXSA-N u2n4xkx7hp Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(O)=O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DRSKVOAJKLUMCL-MMUIXFKXSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
- C12P19/56—Preparation of O-glycosides, e.g. glucosides having an oxygen atom of the saccharide radical directly bound to a condensed ring system having three or more carbocyclic rings, e.g. daunomycin, adriamycin
Definitions
- the present invention relates to an amphiphilic compound, a method for preparing the same, and a surfactant composition comprising the same, specifically, a compound selected from the group consisting of steviol monoglycoside-acid, steviol monoglycoside-ester and steviol monoglycoside-amide, and a method for preparing the same and to a surfactant composition comprising at least one of them.
- Alkylphenol derivatives, phthalates, and isocyanates are classified as chemicals with serious hazards to humans and the environment.
- APs Alkylphenol
- APEOs polyethoxylated derivatives
- the AP mainly used as a commercial surfactant is nonylphenol (NP).
- NPEOs nonylphenol ethoxylate
- paints latex paints
- adhesives inks
- detergents pesticide formulations (emulsions)
- paper industry textile and leather industry
- skimmer chemicals metal working fluids
- metal working fluids It is widely used in cosmetics and detergents.
- metabolites of APEOs are classified as hazardous substances, these substances are released into the environment through various routes without special monitoring.
- NP is known to affect humans and animals as an endocrine blocker. Due to the chemical structure similarity between NPs and the female hormone 17 ⁇ -estradiol, NPs can bind to the estrogen receptor instead of 17 ⁇ -estradiol.
- nonionic active agents SolutolTM, MyrjTM, TweenTM family, etc.
- hydrophilic groups based on polyethylene glycol ((PEG)/polyethyene oxide (PEO) are bonded.
- PEG polyethylene glycol
- PEO polyethyene oxide
- Representative examples include toxic decomposition products (formaldehyde, formic acid, acetaldehyde, etc.) in aqueous systems, harmful effects on product stability and chemical instability, and generation of oxidized peroxo radicals.
- PEG activators are from petrochemicals rather than renewable energy sources, which is another significant disadvantage in terms of the effect of the activators on the environment.
- the present inventors synthesized a novel amphiphilic compound that can be used as a natural-derived eco-friendly surfactant.
- An object of the present invention is to provide a novel amphiphilic compound that can be used as an eco-friendly surfactant and a method for preparing the same.
- Another object of the present invention is to provide a surfactant composition comprising the novel amphiphilic compound.
- the present invention provides an amphiphilic compound represented by Formula (1), Formula (2) or Formula (3).
- R 2 is ⁇ -Glucose- ⁇ -Glucose (2-1), ⁇ -Glucose- ⁇ -Glucose (2-1)- ⁇ -Glucose (3-1), ⁇ -Glucose- ⁇ -Glucose (2-1) It may be one selected from - ⁇ -Rhamnose (3-1) and ⁇ -Glucose- ⁇ -Xylose (2-1)- ⁇ -Glucose (3-1),
- R 3 may be linear or cyclic substituted or unsubstituted C 1 -C 30 alkyl or aryl,
- R 4 and R 5 may each independently be linear or cyclic, substituted or unsubstituted C 1 -C 30 alkyl or aryl, or H.
- one of R 4 and R 5 may be H, and the other may be linear or cyclic substituted or unsubstituted C 1 -C 30 alkyl or aryl.
- the present invention provides a method for preparing an amphipathic compound of Formula (1), comprising hydrolyzing the glycosyle-ester linkage (-CO-OR 1 ) of steviol bisglycoside of Formula (4).
- R 1 may be ⁇ -Glucose or ⁇ -Glucose- ⁇ -Glucose (2-1),
- R 2 is ⁇ -Glucose- ⁇ -Glucose (2-1), ⁇ -Glucose- ⁇ -Glucose (2-1)- ⁇ -Glucose (3-1), ⁇ -Glucose- ⁇ -Glucose (2-1) It may be one selected from - ⁇ -Rhamnose (3-1) and ⁇ -Glucose- ⁇ -Xylose (2-1)- ⁇ -Glucose (3-1).
- the present invention provides a method for preparing an amphiphilic compound of formula (2), comprising the step of esterifying steviol monoglycoside-acid of formula (1) through an alkoxy donor.
- R 2 is ⁇ -Glucose- ⁇ -Glucose (2-1), ⁇ -Glucose- ⁇ -Glucose (2-1)- ⁇ -Glucose (3-1), ⁇ -Glucose- ⁇ -Glucose (2-1) It may be one selected from - ⁇ -Rhamnose (3-1) and ⁇ -Glucose- ⁇ -Xylose (2-1)- ⁇ -Glucose (3-1),
- R 3 may be linear or cyclic, substituted or unsubstituted C 1 -C 30 alkyl or aryl.
- the present invention provides a method for preparing an amphiphilic compound of formula (2), comprising the step of transesterifying steviol bisglycoside of formula (4) through an alkoxy donor.
- R 1 may be ⁇ -Glucose or ⁇ -Glucose- ⁇ -Glucose (2-1),
- R 2 is ⁇ -Glucose- ⁇ -Glucose (2-1), ⁇ -Glucose- ⁇ -Glucose (2-1)- ⁇ -Glucose (3-1), ⁇ -Glucose- ⁇ -Glucose (2-1) It may be one selected from - ⁇ -Rhamnose (3-1) and ⁇ -Glucose- ⁇ -Xylose (2-1)- ⁇ -Glucose (3-1),
- R 3 may be linear or cyclic, substituted or unsubstituted C 1 -C 30 alkyl or aryl.
- the present invention provides a method for preparing an amphiphilic compound of formula (3) comprising the step of amidation of steviol monoglycoside-acid of formula (1) through an amine donor.
- R 2 is ⁇ -Glucose- ⁇ -Glucose (2-1), ⁇ -Glucose- ⁇ -Glucose (2-1)- ⁇ -Glucose (3-1), ⁇ -Glucose- ⁇ -Glucose (2-1) It may be one selected from - ⁇ -Rhamnose (3-1) and ⁇ -Glucose- ⁇ -Xylose (2-1)- ⁇ -Glucose (3-1),
- R 4 and R 5 may each independently be linear or cyclic, substituted or unsubstituted C 1 -C 30 alkyl or aryl, or H.
- the present invention provides a method for preparing an amphiphilic compound of formula (3), comprising the step of transesterifying steviol bisglycoside of formula (4) through an amine donor.
- R 1 may be ⁇ -Glucose or ⁇ -Glucose- ⁇ -Glucose (2-1),
- R 2 is ⁇ -Glucose- ⁇ -Glucose (2-1), ⁇ -Glucose- ⁇ -Glucose (2-1)- ⁇ -Glucose (3-1), ⁇ -Glucose- ⁇ -Glucose (2-1) It may be one selected from - ⁇ -Rhamnose (3-1) and ⁇ -Glucose- ⁇ -Xylose (2-1)- ⁇ -Glucose (3-1),
- R 4 and R 5 may each independently be linear or cyclic, substituted or unsubstituted C 1 -C 30 alkyl or aryl, or H.
- the present invention provides a surfactant composition
- a surfactant composition comprising, as an active ingredient, one or more substances selected from the group consisting of steviol monoglycoside-acid, steviol monoglycoside-ester, and steviol monoglycoside-amide.
- the steviol monoglycoside-acid may be a compound of formula (1).
- R 2 is ⁇ -Glucose- ⁇ -Glucose (2-1), ⁇ -Glucose- ⁇ -Glucose (2-1)- ⁇ -Glucose (3-1), ⁇ -Glucose- ⁇ -Glucose (2) -1)- ⁇ -Rhamnose (3-1) and ⁇ -Glucose- ⁇ -Xylose (2-1)- ⁇ -Glucose (3-1).
- the steviol monoglycoside-ester may be a compound of formula (2).
- R 2 is ⁇ -Glucose- ⁇ -Glucose (2-1), ⁇ -Glucose- ⁇ -Glucose (2-1)- ⁇ -Glucose (3-1), ⁇ -Glucose- ⁇ -Glucose (2) -1)- ⁇ -Rhamnose (3-1) and ⁇ -Glucose- ⁇ -Xylose (2-1)- ⁇ -Glucose (3-1), and R 3 is linear or cyclic substituted or non-substituted cyclic C 1 -C 30 alkyl or aryl.
- the steviol monoglycoside-amide may be a compound of formula (3).
- R 2 is ⁇ -Glucose- ⁇ -Glucose (2-1), ⁇ -Glucose- ⁇ -Glucose (2-1)- ⁇ -Glucose (3-1), ⁇ -Glucose- ⁇ -Glucose (2) -1)- ⁇ -Rhamnose (3-1) and ⁇ -Glucose- ⁇ -Xylose (2-1)- ⁇ -Glucose (3-1), and R 4 and R 5 are each independently linear or cyclic substituted or unsubstituted C 1 -C 30 alkyl or aryl, or H.
- one of R 4 and R 5 may be H, and the other may be linear or cyclic substituted or unsubstituted C 1 -C 30 alkyl or aryl.
- amphiphilic material of the present invention has the advantage that natural steviol diterpenoids act as lipophilic and have hydrophilic glycosyl side chains, thereby providing an environmentally friendly and safe surfactant composition.
- Surfactants are applied to products requiring increased solubility by reducing the surface tension between two immiscible surfaces. It is amphiphilic with a hydrophilic moiety having water solubility and a hydrophobic moiety having lipophilicity.
- soluble active agents spontaneously generate molecular groups (micelles).
- the hydrophobic portion is opposite to the receiving surface, ie facing inward and the hydrophilic portion is facing outward towards the receiving surface. This is a process showing solubility, and the lowest active agent concentration among the active agent concentration conditions capable of generating micelles is called the critical micelle concentration (CMC).
- CMC critical micelle concentration
- CMC is one of the important properties of active agents. Above CMC, micelles are formed when other additional active agents are added. Apart from reaching the CMC, the surface tension also depends on the concentration of the active agent. After reaching the CMC, the surface tension remains relatively constant or without significant change. CMC directly depends on the structure of the active agent, so that when the length of the alkyl group in the structure increases, the CMC decreases and the absorption capacity of the active agent increases. This dependence has a direct and significant impact on the selection and design of active agents. In other words, the increase in absorbency and aggregation according to the increase in the length of the alkyl group enables the desired effect to be achieved only with a lower concentration of the active agent. Thus, the combination of long alkyl group length and long hair is usually beneficial for the functionality of the active agent.
- the leaves of stevia plants (such as Stevia rebaudiana Bertoni), which are perennials, contain high concentrations of natural sweeteners.
- the leaves contain ent-kaurene-type bis-glycosides, such as stevioside, rebaudiosides A, rebaudiosides C, and dulcoside A, which play a typical sweetening role.
- Dried stevia leaves typically contain 5-10% stevioside, 2-4% rebaudioside A, and 1-2% rebaudioside C.
- Such steviol bisglycoside has two hydrophilic glycosyl groups, and the case of application as a surfactant of acids, esters and amides of steviol monoglycoside having a lipophilic diterpene backbone and one hydrophilic glycosyl group as a surfactant is disclosed. no bar
- Steviol monoglycoside obtained by hydrolysis, transesterification or transamidation from steviol bisglycoside, a natural extract shows a remarkably low CMC.
- the CMC of steviol monoglycoside-acid obtained through hydrolysis from rebaudioside A having a CMC of 5.14 mM is 1.1 mM
- the CMC of steviol monoglycoside-ester obtained through transesterification is 0.15 mM
- the CMC of the transamide reaction is 0.15 mM.
- biodegradable and biocompatible ingredients that replace existing harmful substances and provide an eco-friendly approach that utilizes abundant plant ingredients.
- steviol monoglycoside-acid of Formula 1 can be prepared by hydrolysis of the glycosyle-ester linkage (-CO-OR 1 ) of Steviol bisglycoside.
- R 2 is ⁇ -Glucose- ⁇ -Glucose (2-1), ⁇ -Glucose- ⁇ -Glucose (2-1)- ⁇ -Glucose (3-1), ⁇ -Glucose- ⁇ -Glucose (2) -1)- ⁇ -Rhamnose (3-1) and ⁇ -Glucose- ⁇ -Xylose (2-1)- ⁇ -Glucose (3-1).
- Steviol bisglycosides include both the extract itself and the mixture.
- stevioside and rabaudioside E are converted to steviolbioside through glycosyle-ester linkage hydrolysis.
- This glycosyle-ester linkage hydrolysis can be catalyzed by acids or alkalis.
- the resulting Steviol monoglycoside-acids can be used as surfactants due to their amphiphilic structure and properties.
- esterification of steviol monoglycoside-acid can produce steviol monoglycoside-ester of Formula 2 through chemical or biological catalysis with an alcohol of an alkyl group and an aryl group.
- R 2 is ⁇ -Glucose- ⁇ -Glucose (2-1), ⁇ -Glucose- ⁇ -Glucose (2-1)- ⁇ -Glucose (3-1), ⁇ -Glucose- ⁇ -Glucose (2) -1)- ⁇ -Rhamnose (3-1) and ⁇ -Glucose- ⁇ -Xylose (2-1)- ⁇ -Glucose (3-1), and R 3 is linear or cyclic substituted or non-substituted cyclic C 1 -C 30 alkyl or aryl.
- the resulting Steviol monoglycoside-ester can be used as a surfactant through its amphiphilic structure and properties.
- amidation of steviol monoglycoside-acid can produce steviol monoglycoside-amide of Formula 3 through chemical or biological catalysis with an amine of an alkyl group and an aryl group.
- R 2 is ⁇ -Glucose- ⁇ -Glucose (2-1), ⁇ -Glucose- ⁇ -Glucose (2-1)- ⁇ -Glucose (3-1), ⁇ -Glucose- ⁇ -Glucose (2) -1)- ⁇ -Rhamnose (3-1) and ⁇ -Glucose- ⁇ -Xylose (2-1)- ⁇ -Glucose (3-1), and R 4 and R 5 are each independently linear or cyclic substituted or unsubstituted C 1 -C 30 alkyl or aryl, or H.
- one of R 4 and R 5 may be H, and the other may be linear or cyclic substituted or unsubstituted C 1 -C 30 alkyl or aryl.
- the resulting Steviol monoglycoside-amides can be used as surfactants due to their amphiphilic structure and properties.
- Steviol bisglycosides can be carried out through chemical or biological catalysis with an alcohol of each alkyl group and an aryl group and an amine of an alkyl group and an aryl group.
- the resulting products steviol monoglycoside-ester and steviol monoglycoside-amide can be used as surfactants in the form of crude extracts or purified extracts.
- the glycosyl ester linkage of Steviol bisglycosides can be hydrolyzed to the corresponding acid (nearly 100% product selectivity) either via acid or alkali or by enzymatic catalysis. This reaction can be reacted in water through catalysis.
- Acid catalysts include hydrochloric acid, sulfuric acid, hydrofluoric acid, nitric acid, phosophoric acid, toluenesulfonic acid, polystyrene sulfonate, heteropoly acid, zeolites, nitric acid, silico-aluminates, sulfated zirconia, transition metal oxides, cation exchangers, etc.
- alkali catalysts are sodium hydroxide, potassium hydroxide, sodium amide, pyridine, imidazole, DBU(1,8-Diazabicycloundec-7-ene), guanidines, TBD(1,5,7-Triazabicyclo[ 4.4.0]dec-5-ene), solid base, metal oxide (CaO, BaO, MgO), Br ⁇ nsted and Lewis base including anion exchanger can be used.
- Hydrolysis may be carried out through a catalyst in an aqueous condition or water-organic solvent mixture system of -20 to 200 °C.
- Organic solvent can be selected from DMF, DMSO, pyridine, THF, chloroform, dichloromethane, hydrocarbon and cyclic hydrocarbon, alkyl esters, alcohols, ketone and mixtures thereof, but is not limited thereto.
- preferred solutions are water-miscible solvents such as DMF, DMSO, pyridine, THF, alcohols (glycol) and their own mixtures or mixtures thereof.
- the organic solvent may be used in an amount of 1 to 3000% by volume, preferably 10 to 1000% by volume relative to water.
- the optimum temperature may be used in the range of -20 to 200 °C, preferably 10 to 150 °C, more preferably 10 to 100 °C.
- Steviol monoglycoside-acids can be esterified with corresponding esters through the action of acid or alkali catalysts or enzymes through alkoxy donors such as alcohol.
- Acid catalysts include hydrochloric acid, sulfuric acid, hydrofluoric acid, nitric acid, phosophoric acid, toluenesulfonic acid, polystyrene sulfonate, heteropoly acid, zeolites, nitric acid, silico-aluminates, sulfated zirconia, transition metal oxides, cation exchangers, etc.
- alkali catalysts were sodium hydroxide, potassium hydroxide, sodium amide, pyridine, imidazole, DBU (1,8-Diazabicycloundec-7-ene), guanidines, TBD (1,5,7-Triazabicyclo [4.4. 0]dec-5-ene), solid base, metal oxide (CaO, BaO, MgO), Br ⁇ nsted and Lewis base including anion exchanger can be used.
- Hydrolysis may be carried out through a catalyst in an aqueous condition or water-organic solvent mixture system of -20 to 200 °C.
- Organic solvent can be selected from DMF, DMSO, pyridine, THF, chloroform, dichloromethane, hydrocarbon and cyclic hydrocarbon, alkyl esters, alcohols, ketone and mixtures thereof, but is not limited thereto.
- preferred solutions are water-miscible solvents such as DMF, DMSO, pyridine, THF, alcohols (glycol) and their own mixtures or mixtures thereof.
- the organic solvent may be used in an amount of 1 to 3000% by volume, preferably 10 to 1000% by volume relative to water.
- the optimum temperature may be used in the range of -20 to 200 °C, preferably 10 to 150 °C, more preferably 10 to 100 °C.
- Lipase-catalyzed steviol monoglycoside-acid esterification was carried out using alkoxy donors such as Candida antarctica lipase B (Novozym ® 435 (N435)) and alcohols immobilized in a solvent system.
- alkoxy donors such as Candida antarctica lipase B (Novozym ® 435 (N435)
- the ratio of N435 may be in the range of 1 to 300% by volume, preferably 5 to 50% by volume relative to steviol monoglycoside-acid.
- Organic solvent can be selected from DMF, DMSO, pyridine, THF, chloroform, dichloromethane, toluene, hydrocarbon and cyclic hydrocarbon, alkyl esters, alocohols, ketone and mixtures thereof, but is not limited thereto.
- preferred solutions include DMF, DMSO, pyridine, THF, alcohols (glycol) and their own mixtures or mixtures thereof.
- the organic solvent may be used in an amount of 1 to 3000% by volume, preferably 10 to 1000% by volume compared to steviol monoglycoside-acid.
- Alkoxy donors may be used in an amount of 10 to 1000% by volume, preferably 10 to 300% by volume compared to steviol monoglycoside-acid.
- Steviol bisglycoside can be transesterified to the corresponding ester by acid or alkali catalysis through alkoxy donors such as alcohol. This catalytic reaction proceeded with alcohol.
- Acid catalysts include hydrochloric acid, sulfuric acid, hydrofluoric acid, nitric acid, phosophoric acid, toluenesulfonic acid, polystyrene sulfonate, heteropoly acid, zeolites, nitric acid, silico-aluminates, sulfated zirconia, transition metal oxides, cation exchangers, etc.
- alkali catalysts were sodium hydroxide, potassium hydroxide, sodium amide, pyridine, imidazole, DBU (1,8-Diazabicycloundec-7-ene), guanidines, TBD (1,5,7-Triazabicyclo [4.4. 0]dec-5-ene), solid base, metal oxide (CaO, BaO, MgO), Br ⁇ nsted and Lewis base including anion exchanger can be used. Esterification may be carried out through a catalyst in an aqueous condition or water-organic solvent mixture system of -20 to 200 °C.
- Organic solvent can be selected from DMF, DMSO, pyridine, THF, chloroform, dichloromethane, hydrocarbon and cyclic hydrocarbon, alkyl esters, alcohols, ketone and mixtures thereof, but is not limited thereto.
- preferred solutions are water-miscible solvents such as DMF, DMSO, pyridine, THF, alcohols (glycol) and their own mixtures or mixtures thereof.
- the organic solvent may be used in an amount of 1 to 3000% by volume, preferably 10 to 1000% by volume relative to water.
- the optimum temperature may be used in the range of -20 to 200 °C, preferably 10 to 150 °C, more preferably 10 to 100 °C.
- N435 may be in the range of 1 to 300% by volume, preferably 5 to 50% by volume relative to steviol bisglycoside.
- Organic solvent can be selected from DMF, DMSO, pyridine, THF, chloroform, dichloromethane, toluene, hydrocarbon and cyclic hydrocarbon, alkyl esters, alocohols, ketone and mixtures thereof, but is not limited thereto.
- preferred solutions include DMF, DMSO, pyridine, THF, alcohols (glycol) and their own mixtures or mixtures thereof.
- the organic solvent may be used in an amount of 1 to 3000% by volume, preferably 10 to 1000% by volume compared to steviol monoglycoside-acid.
- Amine donors may be used in an amount of 10 to 1000% by volume, preferably 10 to 300% by volume compared to steviol monoglycoside-acid.
- the glycosyl ester linkage of Steviol bisglycosides can be hydrolyzed to the corresponding acid (nearly 100% product selectivity) either via acid or alkali or by enzymatic catalysis. This reaction can be reacted in water through catalysis.
- Acid catalysts include hydrochloric acid, sulfuric acid, hydrofluoric acid, nitric acid, phosophoric acid, toluenesulfonic acid, polystyrene sulfonate, heteropoly acid, zeolites, nitric acid, silico-aluminates, sulfated zirconia, transition metal oxides, cation exchangers, etc.
- alkali catalysts are sodium hydroxide, potassium hydroxide, sodium amide, pyridine, imidazole, DBU(1,8-Diazabicycloundec-7-ene), guanidines, TBD(1,5,7-Triazabicyclo[ 4.4.0]dec-5-ene), solid base, metal oxide (CaO, BaO, MgO), Br ⁇ nsted and Lewis base including anion exchanger can be used.
- Hydrolysis may be carried out through a catalyst in an aqueous condition or water-organic solvent mixture system of -20 to 200 °C.
- Organic solvent can be selected from DMF, DMSO, pyridine, THF, chloroform, dichloromethane, hydrocarbon and cyclic hydrocarbon, alkyl esters, alcohols, ketone and mixtures thereof, but is not limited thereto.
- preferred solutions are water-miscible solvents such as DMF, DMSO, pyridine, THF, alcohols (glycol) and their own mixtures or mixtures thereof.
- the organic solvent may be used in an amount of 1 to 3000% by volume, preferably 10 to 1000% by volume relative to water.
- the optimum temperature may be used in the range of -20 to 200 °C, preferably 10 to 150 °C, more preferably 10 to 100 °C.
- Steviol monoglycoside-acid can be amidated with the corresponding amide by the action of an acid or alkali catalyst or enzyme through amine donors such as alkyl and aryl amine.
- This reaction is catalyzed and/or imidazole, DBU (1,8-Diazabicycloundec-7ene), guanidines, TBD (1,5,7.Triazabicyclo[4.4.0]dec-5-ene), polystyrene-based boronic acid, 2 -Iodophenylboronic aci, 1,3-Bis(2,6-diisopropylphenyl)imidazolum chloride, EDC (1-Etyl3-(3-dimethylaminopropyl)carbodiimide), HATU ((1-[Bis(dimethylamino)methylene]-1H-1, 2,3-triazolo[4,5-b]pyridinium 3-oxide hexafluorophosphate), thi
- This amidation can be carried out with an organic solvent, aqueous condition or water-organic solvent mixture system and - It may proceed through a catalyst at a temperature of 70 to 200 ° C.
- organic solvents are NMP (N-methyl-2-pyrrolidinone), DMF (N,N-dimethylformamide) and DMAc (N,N-dimethylacetamide), DMSO, You can select from pyridine, THF, chloroform, dichloromethane, hydrocarbon and cyclic hydrocarbon, alkyl esters, alcohols, ketone and mixtures thereof, but only these is not limited to
- the organic solvent may be used in an amount of 1 to 3000% by volume, preferably 10 to 1000% by volume relative to water.
- the optimum temperature may be used in the range of -70 to 200 °C, preferably -20 to 150 °C, more preferably -20 to 100 °C.
- Amidation of lipase-catalyzed steviol monoglycoside-acid was carried out using immobilized Candida antarctica lipase B (Novozym ® 435 (N435)) and amine donors such as alkyl and aryl amines in a solvent system.
- the range of amine donors and enzymes includes more than this reaction.
- the ratio of N435 may be in the range of 1 to 300% by volume, preferably 5 to 50% by volume relative to steviol monoglycoside-acid.
- Organic solvents include NMP (N-methyl-2-pyrrolidinone), DMF (N,N-dimethylformamide) and DMAc (N,N-dimethylacetamide), DMSO, pyridine, THF, chloroform, dichloromethane, toluene, hydrocarbon and cyclic hydrocarbon, alkyl It is possible to select from esters, alocohols, ketones, and mixtures thereof, but is not limited thereto. Among these, preferred solutions are NMP (N-methyl-2-pyrrolidinone), DMF (N,N-dimethylformamide) and DMAc (N,N-dimethylacetamide), DMSO, pyridine, THF, alcohols (glycol), and their own mixtures.
- NMP N-methyl-2-pyrrolidinone
- DMF N,N-dimethylformamide
- DMAc N,N-dimethylacetamide
- DMSO pyridine, THF, alcohols (glycol), and their
- the organic solvent may be used in an amount of 1 to 3000% by volume, preferably 10 to 1000% by volume compared to steviol monoglycoside-acid.
- Amine donors may be used in an amount of 10 to 1000% by volume, preferably 10 to 300% by volume compared to steviol monoglycoside-acid.
- Various amidases from various sources can be used in this reaction.
- the optimum temperature for lipases such as Candida antarctica lipase B listed in the academic literature is 60 °C, but it may vary depending on the solution used or the reaction time.
- Product selectivity and product yield of the production process in the present invention may also vary depending on conditions.
- Steviol bisglycoside can be amidated with the corresponding amide through the action of acid or alkali catalysts or enzymes through amine donors such as alkyl and aryl amines.
- This reaction is catalyzed and/or imidazole, DBU(1,8-Diazabicycloundec-7ene), guanidines, TBD(1,5,7.Triazabicyclo[4.4.0]dec-5-ene), polystyrene-based boronic acid, 2 -Iodophenylboronic aci, 1,3-Bis(2,6-diisopropylphenyl)imidazolum chloride, EDC(1-Etyl3-(3-dimethylaminopropyl)carbodiimide), HATU((1-[Bis(dimethylamino)methylene]-1H-1, 2,3-triazolo[4,5-b]pyridinium 3-oxide hexafluorophosphate), thi
- Br ⁇ nsted and Lewis acids including acid, toluenesulfonic acid, polystyrene sulfonate, heteropoly acid, zeolites, nitric acid, silico-aluminates, sulfated zirconia, transition metal oxides, cation exchanger, etc.
- alkali catalyst is sodium hydroxide, potassium hydroxide, sodium amide , pyridine, imidazole , DBU(1,8-Diazabicycloundec-7-ene), guanidines, TBD(1,5,7-Triazabicyclo[4.4.0]dec-5-ene), solid base, metal oxide (CaO, BaO, MgO), Br ⁇ nsted and Lewis bases including anion exchangers can be used.
- This amidation may be carried out through an organic solvent, an aqueous condition or a water-organic solvent mixture system and a catalyst at a temperature of -70 to 200 °C.
- organic solvents are NMP (N-methyl-2-pyrrolidinone), DMF (N,N-dimethylformamide) and DMAc (N,N-dimethylacetamide), DMSO, pyridine, THF, chloroform, dichloromethane, hydrocarbon and cyclic hydrocarbon, alkyl It can be selected from esters, alcohols, ketones, and mixtures thereof, but is not limited thereto.
- the organic solvent may be used in an amount of 1 to 3000% by volume, preferably 10 to 1000% by volume relative to water.
- the optimum temperature may be used in the range of -70 to 200 °C, preferably -20 to 150 °C, more preferably -20 to 100 °C.
- Lipase-catalyzed amidation of steviol bisglycosides was carried out in a solvent system using immobilized Candida antarctica lipase B (Novozym ® 435 (N435)) and amine donors such as alkyl and aryl amines.
- the range of amine donors and enzymes includes more than this reaction.
- the proportion of N435 may be in the range of 1 to 300% by volume, preferably 5 to 50% by volume relative to steviol bisglycoside.
- Organic solvents include NMP (N-methyl-2-pyrrolidinone), DMF (N,N-dimethylformamide) and DMAc (N,N-dimethylacetamide), DMSO, pyridine, THF, chloroform, dichloromethane, toluene, hydrocarbon and cyclic hydrocarbon, alkyl It is possible to select from esters, alocohols, ketones, and mixtures thereof, but is not limited thereto. Among these, the preferred solutions are NMP (N-methyl-2-pyrrolidinone), DMF (N,N-dimethylformamide) and DMAc (N,N-dimethylacetamide), DMSO, pyridine, THF, alcohols (glycol) and their own mixtures.
- the organic solvent may be used in an amount of 1 to 3000% by volume, preferably 10 to 1000% by volume compared to steviol monoglycoside-acid.
- Amine donors may be used in an amount of 10 to 1000% by volume, preferably 10 to 300% by volume compared to steviol monoglycoside-acid.
- Various amidases from various sources can be used in this reaction.
- the optimum temperature for lipases such as Candida antarctica lipase B listed in the academic literature is 60 °C, but it may vary depending on the solution used or the reaction time.
- Product selectivity and product yield of the production process in the present invention may also vary depending on conditions.
- the alkali catalyst solution (Phosphine/I 2 /Base) was prepared by adding I 2 (0.15 mmol) to 2 mL of CH 2 Cl 2 and then imidazole (0.33 mmol). 64.3 mg (0.1 mmol) of the product obtained in Example 1 was added to the catalyst solution, mixed at room temperature for 5 minutes, and then ethanol (0.15 mmol) was added. After reaction for 15 hours, 2mL of CH 2 Cl 2 was added, washed with 2N HCl and water, dried using anhydrous Na 2 SO 4 to obtain a crude solid product.
- the alkali catalyst solution (Phosphine/I 2 /Base) was prepared by adding I 2 (0.15 mmol) to 2 mL of CH 2 Cl 2 and then imidazole (0.33 mmol). 64.3 mg (0.1 mmol) of the product obtained in Example 1 was added to the catalyst solution, mixed at room temperature for 5 minutes, and then n-octylamine (0.15 mmol) was added. After reaction for 15 hours, 2mL of CH 2 Cl 2 was added, washed with 2N HCl and water, dried using anhydrous Na 2 SO 4 to obtain a crude solid product.
- HLB Hydrophile-Lipophile Balance
- HLB values of the results of Examples 1 to 3 calculated based on the hydrophilic group and molecular weight were 10.6, 10.2, and 9.1, respectively.
- the range of HLB values can be adjusted by placing various alcohol and amine side chains as lipophilic groups.
- Example 4 The foam properties of steviol monoglycoside-ester obtained in Example 4 were confirmed. 5 mL of distilled water and 10 mg of steviol monoglycoside-ester obtained in Example 4 were added to a measuring cylinder, mixed to form micelles, shaken for 10 seconds to generate foam, and then left at room temperature to compare the amount of foam.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Saccharide Compounds (AREA)
Abstract
Description
Product | R1 | R2 |
Stevioside | β-Glucose | β-Glucose-β-Glucose(2-1) |
Rebaudioside A | β-Glucose | β-Glucose-β-Glucose(2-1)-β-Glucose(3-1) |
Rebaudioside C | β-Glucose | β-Glucose-β-Glucose(2-1)-β-Rhamnose(3-1) |
Rebaudioside D | β-Glucose-β-Glucose(2-1) | β-Glucose-β-Glucose(2-1)-β-Glucose(3-1) |
Rebaudioside E | β-Glucose-β-Glucose(2-1) | β-Glucose-β-Glucose(2-1) |
Rebaudioside F | β-Glucose | β-Glucose-β-Glucose(2-1)-β-Glucose(3-1) |
Dulcoside A | β-Glucose | β-Glucose-β-Xylose(2-1)-β-Glucose(3-1) |
Claims (12)
- 화학식 (1), 화학식 (2) 또는 화학식 (3)으로 표시되는 양친매성 화합물:상기 화학식에서,R2는 β-Glucose-β-Glucose(2-1), β-Glucose-β-Glucose(2-1)-β-Glucose(3-1), β-Glucose-β-Glucose(2-1)-β-Rhamnose(3-1) 및 β-Glucose-β-Xylose(2-1)-β-Glucose(3-1)에서 선택되는 하나이고;R3는 선형 또는 환형의 치환 또는 비치환된 C1-C30 알킬 또는 아릴이며;R4 및 R5는 각각 독립적으로 선형 또는 환형의 치환 또는 비치환된 C1-C30 알킬 또는 아릴, 또는 H이다.
- 제1항에 있어서,상기 R4 및 R5 중 하나는 H이고, 다른 하나는 선형 또는 환형의 치환 또는 비치환된 C1-C30 알킬 또는 아릴인 것을 특징으로 하는 양친매성 화합물.
- 화학식 (4)의 steviol bisglycoside의 glycosyle-ester linkage(-CO-OR1)를 가수분해하는 단계를 포함하는 것을 특징으로 하는 화학식 (1)의 양친매성 화합물의 제조방법:상기 화학식에서,R1은 β-Glucose 또는 β-Glucose-β-Glucose(2-1)이고;R2는 β-Glucose-β-Glucose(2-1), β-Glucose-β-Glucose(2-1)-β-Glucose(3-1), β-Glucose-β-Glucose(2-1)-β-Rhamnose(3-1) 및 β-Glucose-β-Xylose(2-1)-β-Glucose(3-1)에서 선택되는 하나이다.
- 화학식 (1)의 steviol monoglycoside-acid에 alkoxy donor를 통해 에스테르화하는 단계를 포함하는 것을 특징으로 하는 화학식 (2)의 양친매성 화합물의 제조방법:상기 화학식에서,R2는 β-Glucose-β-Glucose(2-1), β-Glucose-β-Glucose(2-1)-β-Glucose(3-1), β-Glucose-β-Glucose(2-1)-β-Rhamnose(3-1) 및 β-Glucose-β-Xylose(2-1)-β-Glucose(3-1)에서 선택되는 하나이고;R3는 선형 또는 환형의 치환 또는 비치환된 C1-C30 알킬 또는 아릴이다.
- 화학식 (4)의 steviol bisglycoside에 alkoxy donor를 통해 전이에스테르화하는 단계를 포함하는 것을 특징으로 하는 화학식 (2)의 양친매성 화합물의 제조방법:상기 화학식에서,R1은 β-Glucose 또는 β-Glucose-β-Glucose(2-1)이고;R2는 β-Glucose-β-Glucose(2-1), β-Glucose-β-Glucose(2-1)-β-Glucose(3-1), β-Glucose-β-Glucose(2-1)-β-Rhamnose(3-1) 및 β-Glucose-β-Xylose(2-1)-β-Glucose(3-1)에서 선택되는 하나이며;R3는 선형 또는 환형의 치환 또는 비치환된 C1-C30 알킬 또는 아릴이다.
- 화학식 (1)의 steviol monoglycoside-acid에 amine donor를 통해 아미드화하는 단계를 포함하는 것을 특징으로 하는 화학식 (3)의 양친매성 화합물의 제조방법:상기 화학식에서,R2는 β-Glucose-β-Glucose(2-1), β-Glucose-β-Glucose(2-1)-β-Glucose(3-1), β-Glucose-β-Glucose(2-1)-β-Rhamnose(3-1) 및 β-Glucose-β-Xylose(2-1)-β-Glucose(3-1)에서 선택되는 하나이고;R4 및 R5는 각각 독립적으로 선형 또는 환형의 치환 또는 비치환된 C1-C30 알킬 또는 아릴, 또는 H이다.
- 화학식 (4)의 steviol bisglycoside에 amine donor를 통해 전이에스테르화하는 단계를 포함하는 것을 특징으로 하는 화학식 (3)의 양친매성 화합물의 제조방법:상기 화학식에서,R1은 β-Glucose 또는 β-Glucose-β-Glucose(2-1)이고;R2는 β-Glucose-β-Glucose(2-1), β-Glucose-β-Glucose(2-1)-β-Glucose(3-1), β-Glucose-β-Glucose(2-1)-β-Rhamnose(3-1) 및 β-Glucose-β-Xylose(2-1)-β-Glucose(3-1)에서 선택되는 하나이며;R4 및 R5는 각각 독립적으로 선형 또는 환형의 치환 또는 비치환된 C1-C30 알킬 또는 아릴, 또는 H이다.
- steviol monoglycoside-acid, steviol monoglycoside-ester 및 steviol monoglycoside-amide로 구성되는 군에서 선택되는 하나 이상의 물질을 유효성분으로 포함하는 것을 특징으로 하는 계면활성제 조성물.
- 제1항에 있어서,상기 steviol monoglycoside-amide는 화학식 (3)의 화합물인 것을 특징으로 하는 계면활성제 조성물:식 중, R2는 β-Glucose-β-Glucose(2-1), β-Glucose-β-Glucose(2-1)-β-Glucose(3-1), β-Glucose-β-Glucose(2-1)-β-Rhamnose(3-1) 및 β-Glucose-β-Xylose(2-1)-β-Glucose(3-1)에서 선택되는 하나이고,R4 및 R5는 각각 독립적으로 선형 또는 환형의 치환 또는 비치환된 C1-C30 알킬 또는 아릴, 또는 H이다.
- 제4항에 있어서,상기 R4 및 R5 중 하나는 H이고, 다른 하나는 선형 또는 환형의 치환 또는 비치환된 C1-C30 알킬 또는 아릴인 것을 특징으로 하는 계면활성제 조성물.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18/283,016 US20240182508A1 (en) | 2022-02-28 | 2022-04-11 | Amphipathic compound, preparation method therefor, and surfactant composition comprising same |
EP22788377.4A EP4324838A1 (en) | 2021-04-12 | 2022-04-11 | Amphipathic compound, preparation method therefor, and surfactant composition comprising same |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202163173718P | 2021-04-12 | 2021-04-12 | |
US63/173,718 | 2021-04-12 | ||
KR10-2022-0025992 | 2022-02-28 | ||
KR1020220025992A KR20220141223A (ko) | 2021-04-12 | 2022-02-28 | 양친매성 화합물, 이의 제조방법 및 이를 포함하는 계면활성제 조성물 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022220521A1 true WO2022220521A1 (ko) | 2022-10-20 |
Family
ID=83640471
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2022/005227 WO2022220521A1 (ko) | 2021-04-12 | 2022-04-11 | 양친매성 화합물, 이의 제조방법 및 이를 포함하는 계면활성제 조성물 |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP4324838A1 (ko) |
WO (1) | WO2022220521A1 (ko) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20120027363A (ko) * | 2009-06-16 | 2012-03-21 | 이피씨 (베이징) 내추럴 프로덕츠 컴퍼니, 리미티드 | 뒷맛을 감소시키거나 제거하기 위한 레바우디오사이드 d를 포함하는 조성물 및 그의 제조 방법 |
KR20130014451A (ko) * | 2011-07-29 | 2013-02-07 | 한국생명공학연구원 | 스테비올 배당체 또는 감초, 및 난용성 물질을 포함하는 복합체 |
KR20160109969A (ko) * | 2015-03-09 | 2016-09-21 | 서울대학교산학협력단 | 용해도가 개선된 난용성 소재와 스테비올 배당체의 복합체 제조 방법 및 이에 의하여 제조된 용해도가 개선된 난용성 소재와 스테비올배당체의 복합체 |
-
2022
- 2022-04-11 WO PCT/KR2022/005227 patent/WO2022220521A1/ko active Application Filing
- 2022-04-11 EP EP22788377.4A patent/EP4324838A1/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20120027363A (ko) * | 2009-06-16 | 2012-03-21 | 이피씨 (베이징) 내추럴 프로덕츠 컴퍼니, 리미티드 | 뒷맛을 감소시키거나 제거하기 위한 레바우디오사이드 d를 포함하는 조성물 및 그의 제조 방법 |
KR20130014451A (ko) * | 2011-07-29 | 2013-02-07 | 한국생명공학연구원 | 스테비올 배당체 또는 감초, 및 난용성 물질을 포함하는 복합체 |
KR20160109969A (ko) * | 2015-03-09 | 2016-09-21 | 서울대학교산학협력단 | 용해도가 개선된 난용성 소재와 스테비올 배당체의 복합체 제조 방법 및 이에 의하여 제조된 용해도가 개선된 난용성 소재와 스테비올배당체의 복합체 |
Non-Patent Citations (2)
Title |
---|
KHATTAB SHERINE N.; MASSOUD MONA I.; ABD EL-RAZEK AMAL M.; EL-FAHAM AYMAN: "Physico-chemical and sensory characteristics of steviolbioside synthesized from stevioside and its application in fruit drinks and food", JOURNAL OF FOOD SCIENCE AND TECHNOLOGY, SPRINGER (INDIA) PRIVATE LTD., INDIA, vol. 54, no. 1, 18 January 2017 (2017-01-18), India , pages 185 - 195, XP036153650, ISSN: 0022-1155, DOI: 10.1007/s13197-016-2450-2 * |
LEE LIN-WEN, LEE TZONG-HUEI, LIN CHING-TUNG, CHEN TIFFANY, LIN PEN-YUAN: "Mass Spectra Analyses of Amides and Amide Dimers of Steviol, Isosteviol, and Steviolbioside", INTERNATIONAL JOURNAL OF SPECTROSCOPY, vol. 2012, no. 9, 12 April 2012 (2012-04-12), pages 1 - 9, XP055976846, ISSN: 1687-9449, DOI: 10.1155/2012/894891 * |
Also Published As
Publication number | Publication date |
---|---|
EP4324838A1 (en) | 2024-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2014030838A1 (ko) | 가소제 조성물 | |
US2714607A (en) | Polyethoxy esters of p-butylaminobenzoic acid | |
WO2011004980A2 (ko) | 트리사이클릭 유도체의 제조방법 | |
WO2020101234A1 (ko) | 5-히드록시메틸퍼퓨랄로부터 2,5-퓨란디메탄올 및 2,5-테트라히드로퓨란 디메탄올의 제조방법 | |
WO2022220521A1 (ko) | 양친매성 화합물, 이의 제조방법 및 이를 포함하는 계면활성제 조성물 | |
WO2009142423A2 (en) | A method for preparing high-purity polyethyleneglycol aldehyde derivatives | |
AU2007336365B2 (en) | Process for preparing 3,5-di-Omicron-acyl-2-fluoro-2-C-methyl-D-ribono-gamma-lactone | |
WO2017126847A1 (ko) | 3-((2s,5s)-4-메틸렌-5-(3-옥소프로필)테트라히드로퓨란-2-일)프로판올 유도체의 제조방법 및 이를 위한 중간체 | |
FI69472C (fi) | Foerfarande foer framstaellning av estrar av polyenmakrolidantibiotika och deras n-substituerade derivat | |
Fregapane et al. | Facile chemo-enzymatic synthesis of monosaccharide fatty acid esters | |
KR20220141223A (ko) | 양친매성 화합물, 이의 제조방법 및 이를 포함하는 계면활성제 조성물 | |
WO2021125708A1 (ko) | 지방아민 컨쥬게이션된 니코틴아미드 리보사이드 유도체 | |
US4857641A (en) | C.12 modified erythromycin A derivatives | |
WO2010114305A2 (ko) | 페길레이션된 베튤린 유도체 및 그를 포함하는 화장료 조성물 | |
US20240182508A1 (en) | Amphipathic compound, preparation method therefor, and surfactant composition comprising same | |
CN113149879B (zh) | 一种4-硒代萘酯或4-硒代萘酰胺的制备方法 | |
Schuur et al. | A synthetic strategy for novel nonsymmetrical bola amphiphiles based on carbohydrates | |
EP0243646B1 (en) | A process for the preparation of forskolin from 9-deoxy-forskolin and intermediates used therein | |
WO2013035899A1 (ko) | 5-히드록시-1, 3-디옥산의 제조 방법 및 이를 원료로 한 분기형 글리세롤 3량체의 제조 방법 | |
WO2018062729A1 (ko) | 유사 세라마이드 화합물 및 그 제조방법 | |
EP3941911A1 (en) | Method for the synthesis of 2,5-furandicarboxylic acid | |
Dutta et al. | Synthesis and properties of the naturally occurring N-[(9-β-D-ribofuranosylpurin-6-yl)-N-methylcarbamoyl]-L-threonine (mt6A) and other related synthetic analogs | |
JPS5511533A (en) | Preparation of 2-amino-4-acylaminophenyl ether | |
WO2017111380A1 (ko) | 살리실산 유도체와 그 제조방법 및 이를 포함하는 미백용 화장료 조성물 | |
WO2024058311A1 (ko) | 엑토인의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22788377 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 18283016 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2022788377 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2022788377 Country of ref document: EP Effective date: 20231113 |